最終更新日：2022/12/24
Oral bisphosphonates were the predominant treatment recommended by physicians with 35 of the 44 patients reporting that their physician recommended alendronate, ibandronate, or risedronate (Table 4).
編集履歴（0）
Oral bisphosphonates were the predominant treatment recommended by physicians with 35 of the 44 patients reporting that their physician recommended alendronate, ibandronate, or risedronate (Table 4).
DiQt（ディクト）
無料
★★★★★★★★★★
